LWAC
BMRN icon

Laurel Wealth Advisors (California)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,955
Closed -$228K – 663
2022
Q1 		$228K Buy
+2,955
New +$228K 0.02% 676